Composition for preventing or treating inflammatory bowel disease
AssigneeAjou University Industry-Academic Cooperation Foundation
InventorSeong Hyang Sohn
Life of this patent
Estimating the term…
Loading patent…
AssigneeAjou University Industry-Academic Cooperation Foundation
InventorSeong Hyang Sohn
Estimating the term…
The present invention relates to a composition for preventing or treating inflammatory bowel disease. More specifically, the present invention provides a pharmaceutical composition and a health food composition for preventing or treating inflammatory bowel disease, comprising, as active ingredients, two or more strains selected from the group consisting of Tetragenococcus halophilus, Eubacterium rectale, and Lactobacillus animalis; and cultures of the strains, concentrates of the cultures, extracts of the cultures, or lysates thereof. The composition comprises two or more strains having anti-inflammatory activity as an active ingredient and regulates immune cells related to inflammatory bowel disease, thereby preventing, ameliorating or treating inflammatory bowel disease more effectively than a single strain.
A pharmaceutical composition for preventing or treating an inflammatory bowel disease, comprising, as active ingredients, a mixture of species comprising Tetragenococcus halophilus, Eubacterium rectale, and Lactobacillus animalis;
A health food composition for preventing or ameliorating an inflammatory bowel disease, comprising, as active ingredients, a mixture of species comprising Tetragenococcus halophilus, Eubacterium rectale, and Lactobacillus animalis;
Dependencies are inferred from the claim text.